Literature DB >> 16368262

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.

Robert F Pass1, Karen B Fowler, Suresh B Boppana, William J Britt, Sergio Stagno.   

Abstract

BACKGROUND: The relationship between gestational age at time of maternal cytomegalovirus (CMV) infection and outcome of fetal infection is not well defined because the timing of maternal infection is usually not known.
OBJECTIVE: To determine whether congenital cytomegalovirus (CMV) infection following primary maternal infection during the first trimester of pregnancy is more likely to lead to central nervous system (CNS) sequelae than fetal infection due to maternal infection later in pregnancy. STUDY
DESIGN: Using serum collected during pregnancy from mothers of newborns with congenital CMV infection, maternal infection was categorized as first trimester (<13 weeks) or later based on dates and results of IgG and IgM assays for CMV antibody. Outcome of congenital CMV infection was assessed by longitudinal fotlow-up of the infected cohort.
RESULTS: Sensorineural hearing loss was found in 8/34 (24%) of children in the first trimester group, compared with 1/40 (2.5%) in the later infection group (P=0.01, relative risk, 9.6). Considering any CNS sequela (hearing loss, mental retardation, cerebral palsy, seizures, chorioretinitis) 11/34 (32%) first trimester cases were affected compared with 6/40 (15%) in the later infection group (P=0.07, relative risk 2.2). None of the later group had more than one sequela, compared with 4 (12%) of the first trimester group (P=0.04).
CONCLUSIONS: Children with congenital CMV infection following first trimester maternal infection are more likely to have CNS sequelae, especially sensorineural hearing loss, than are those whose mothers were infected later in pregnancy. However, some degree of CNS impairment can follow even late gestational infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368262     DOI: 10.1016/j.jcv.2005.09.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  99 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

2.  Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study.

Authors:  Maik Dorn; Karen Lidzba; Andrea Bevot; Rangmar Goelz; Till-Karsten Hauser; Marko Wilke
Journal:  Hum Brain Mapp       Date:  2013-09-11       Impact factor: 5.038

3.  Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Authors:  Ying-Liang Duan; Han-Qing Ye; Anamaria G Zavala; Cui-Qing Yang; Ling-Feng Miao; Bi-Shi Fu; Keun Seok Seo; Christian Davrinche; Min-Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

Authors:  Lenore Pereira; Matthew Petitt; Alex Fong; Mitsuru Tsuge; Takako Tabata; June Fang-Hoover; Ekaterina Maidji; Martin Zydek; Yan Zhou; Naoki Inoue; Sanam Loghavi; Samuel Pepkowitz; Lawrence M Kauvar; Dotun Ogunyemi
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

Review 5.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

6.  Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research.

Authors:  Gai L McMichael; Amanda R Highet; Catherine S Gibson; Paul N Goldwater; Michael E O'Callaghan; Emily R Alvino; Alastair H MacLennan
Journal:  J Biomol Tech       Date:  2011-04

7.  Cytomegalovirus Infection in Pregnancy - Counselling Challenges in the Setting of Generalised Testing.

Authors:  Anca Maria Ciobanu; Nicolae Gica; Corina Gica; Radu Botezatu; Mirona Furtuna; Gheorghe Peltecu; Anca Maria Panaitescu
Journal:  Maedica (Bucur)       Date:  2020-06

8.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

Review 9.  Congenital cytomegalovirus infection: new prospects for prevention and therapy.

Authors:  Elizabeth C Swanson; Mark R Schleiss
Journal:  Pediatr Clin North Am       Date:  2013-04       Impact factor: 3.278

Review 10.  Detection of congenital cytomegalovirus in newborns using nucleic acid amplification techniques and its public health implications.

Authors:  Guoyu Liu; Rong Hai; Fenyong Liu
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.